Fecal calprotectin level in healthy children aged less than 4 years in South Korea

Journal of Clinical Laboratory Analysis

Volumn 31, Issue 6, 2017, Pages

  Song, Joo Young ^a   Lee, Yoo Mi ^a   Choi, You Jin ^a   Jeong, Su Jin ^a  

^a CHA University   (South Korea)

Author keywords

calprotectin; gut maturation; infant; reference values; South Korea

Indexed keywords

CALGRANULIN;

ACCURACY; ANALYTICAL PARAMETERS; ARTICLE; CHILD; CONTROLLED STUDY; FECAL CALPROTECTIN LEVEL; FECES ANALYSIS; FEMALE; GROUPS BY AGE; HUMAN; HUMAN EXPERIMENT; INFANT; KINDERGARTEN; LIMIT OF DETECTION; MALE; NORMAL HUMAN; QUESTIONNAIRE; REFERENCE VALUE; CHEMISTRY; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FECES; PRESCHOOL CHILD; SOUTH KOREA;

CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; FECES; FEMALE; HUMANS; INFANT; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; REFERENCE VALUES; REPUBLIC OF KOREA;

EID: 85010903670     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.22113     Document Type: Article

References (26)

1. Nakashige TG, Zhang B, Krebs C, Nolan EM. Human calprotectin is an iron-sequestering host-defense protein. Nat Chem Biol. 2015;11:765–771.
2. Johne B, Fagerhol M, Lyberg T, et al. Functional and clinical aspects of the myelomonocyte protein calprotectin. Mol Pathol. 1997;50:113.
3. Limburg PJ, Ahlquist DA, Sandborn WJ, et al. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy. Am J Gastroenterol. 2000;95:2831–2837.
4. Alibrahim B, Aljasser MI, Salh B. Fecal calprotectin use in inflammatory bowel disease and beyond: a mini-review. Can J Gastroenterol Hepatol. 2015;29:157–163.
5. Fagerberg UL, Lööf L, Lindholm J, Hansson L-O, Finkel Y. Fecal calprotectin: a quantitative marker of colonic inflammation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007;45:414–420.
6. TrilloBelizon C, Ortega Páez E, Medina Claros AF, et al. Faecal calprotectin as an aid to the diagnosis of non-IgE mediated cow's milk protein allergy. An Pediatr (Barc). 2016;84:318–323.
7. Orivuori L, Mustonen K, de Goffau MC, et al. High level of fecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6. Clin Exp Allergy. 2015;45:928–939.
8. Merras-Salmio L, Kolho KL, Pelkonen AS, Kuitunen M, Makela MJ, Savilahti E. Markers of gut mucosal inflammation and cow's milk specific immunoglobulins in non-IgE cow's milk allergy. Clin Transl Allergy. 2015;4:8.
9. Beşerz ÖF, Sancak S, Erkan T, Kutlu T, Çokuğraş H, Çokuğraş FÇ. Can fecal calprotectin level be used as a markers of inflammation in the diagnosis and follow-up of cow's milk protein allergy? Allergy Asthma Immunol Res. 2014;6:33–38.
10. Baldassarre ME, Fanelli M, Lasorella ML, et al. Fecal calprotectin (FC) in newborns: is it a predictive marker of gastrointestinal and/or allergic disease? Immunopharmacol Immunotoxicol. 2011;33:220–223.
11. Avershina E, Storrø O, Øien T, et al. Bifidobacterial succession and correlation networks in a large unselected cohort of mothers and their children. Appl Environ Microbiol. 2013;79:497–507.
12. Liu JR, Sheng XY, Hu YQ, et al. Fecal calprotectin levels are higher in rural than in urban Chinese infants and negatively associated with growth. BMC Pediatr. 2012;12:129.
13. Bunn SK, Bisset WM, Main MJ, Golden BE. Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001;32:171–177.
14. Olafsdottir E, Aksnes L, Fluge G, Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Actapaediatrica. 2002;91:45–50.
15. Rugtveit J, Fagerhol MK. Age-dependent variations in fecal calprotectin concentrations in children. J Pediatr Gastroenterol Nutr. 2002;34:323.
16. Fagerberg UL, Lööf L, Merzoug RD, Hansson L-O, Finkel Y. Fecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr. 2003;37:468–472.
17. Canani RB, Rapacciuolo L, Romano M, et al. Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice. Dig Liv Dis. 2004;36:467–470.
18. Bremner A, Roked S, Robinson R, Phillips I, Beattie M. Faecal calprotectin in children with chronic gastrointestinal symptoms. Acta Paediatr. 2005;94:1855–1858.
19. Hestvik E, Tumwine JK, Tylleskar T, et al. Faecal calprotectin concentrations in apparently healthy children aged 0-12 years in urban Kampala, Uganda: a community-based survey. BMC Pediatr. 2011;11:9.
20. Oord T, Hornung N. Fecal calprotectin in healthy children. ScandClin Lab Invest. 2014;74:254–258.
21. Zhu Q, Li F, Wang J, Shen L, Sheng X. Fecal calprotectin in healthy children aged 1-4 years. PLoS ONE. 2016;11:e0150725.
22. Li F, Ma J, Geng S, Wang J, Ren F, Sheng X. Comparison of the different kinds of feeding on the level of fecal calprotectin. Early Hum Dev. 2014;90:471–475.
23. Ambe PC, Gödde D, Bönicke L, Papadakis M, Störkel S, Zirngibl H. Calprotectin could be a potential biomarker for acute appendicitis. J Transl Med. 2016;14:107.
24. Kanik A, Baran M, Ince FD, et al. Faecal calprotectin levels in children with Henoch–Schönlein purpura: is this a new marker for gastrointestinal involvement? Eur J Gastroenterol Hepatol. 2015;27:254–258.
25. Pezzilli R, Barassi A, Labate AM, et al. Fecal calprotectin levels in patients with colonic polyposis. Dig Dis Sci. 2008;53:47–51.
26. Pergialiotis V, Konstantopoulos P, Karampetsou N, et al. Calprotectin levels in necrotizing enterocolitis: a systematic review of the literature. Inflamm Res. 2016;65:1–6.